Cargando…

(18)F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma

PURPOSE: Multiple myeloma (MM), the second most hematological malignancy, have been studied extensively in the prognosis of the clinical parameters, however there are only a few studies have discussed the role of dual modalities and multiple algorithms of (18)F-FDG ((18)F-fluorodeoxyglucose) PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Haoshu, Huang, Delong, Wu, Junhao, Chen, Xiaomin, Chen, Yue, Huang, Chunlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303834/ https://www.ncbi.nlm.nih.gov/pubmed/37370013 http://dx.doi.org/10.1186/s12880-023-01033-2

Ejemplares similares

Application of 18F-FDG PET-CT Images Based Radiomics in Identifying Vertebral Multiple Myeloma and Bone Metastases
por: Jin, Zhicheng, et al.
Publicado: (2022)

PET/CT in Multiple Myeloma: Beyond FDG
por: Matteucci, Federica, et al.
Publicado: (2021)

PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma
por: Martí, Alejandro, et al.
Publicado: (2021)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

Machine Learning Model Based on Optimized Radiomics Feature from (18)F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A Preliminary Study
por: Ni, Beiwen, et al.
Publicado: (2023)

Radiomics analysis of bone marrow biopsy locations in [(18)F]FDG PET/CT images for measurable residual disease assessment in multiple myeloma
por: Milara, Eva, et al.
Publicado: (2023)

Detection of Extramedullary Multiple Myeloma in Liver by FDG-PET/CT
por: Kim, Dae-Weung, et al.
Publicado: (2013)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

Case of non‐secretory multiple myeloma eventually diagnosed by (18)F‐FDG PET/CT
por: Haratake, Daisuke, et al.
Publicado: (2022)

Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022)

P921: ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS FOR RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Shreve, Jacob, et al.
Publicado: (2023)

(11)C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to (18)F-FDG PET/CT and Prognostic Value
por: Morales-Lozano, Maria I., et al.
Publicado: (2022)

(18)FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
por: Lapa, Constantin, et al.
Publicado: (2014)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
por: Wu, Junhao, et al.
Publicado: (2022)

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI
por: Papamichail, Dimitris, et al.
Publicado: (2019)

(11)C-choline vs. (18)F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
por: Nanni, Cristina, et al.
Publicado: (2007)

The prognostic significance of [(18)F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
por: Sachpekidis, Christos, et al.
Publicado: (2021)

18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?
por: Zukovs, Romans, et al.
Publicado: (2022)

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma
por: Westerland, Olwen, et al.
Publicado: (2021)

Comparison of [(18)F]FDG PET/CT and MRI for Treatment Response Assessment in Multiple Myeloma: A Meta-Analysis
por: Yokoyama, Kota, et al.
Publicado: (2021)

Prognostic value of semi-quantitative parameters of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients
por: Wan, Baoyu, et al.
Publicado: (2022)

Radiomics–clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma
por: Ding, Jianming, et al.
Publicado: (2023)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

(18)F-FDG and (11)C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
por: Morales-Lozano, Maria I, et al.
Publicado: (2020)

Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022)

Proposal for a Quantitative (18)F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma
por: Takahashi, Maria E. S., et al.
Publicado: (2019)

Application of an artificial intelligence-based tool in [(18)F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Multimodality Imaging Including PET/CT in a Patient with Amyloid Arthropathy and Multiple Myeloma
por: dos Reis Teixeira, Afrânio, et al.
Publicado: (2016)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

P812: PREDICTING HIGH-RISK DISEASE BIOLOGY USING ARTIFICIAL INTELLIGENCE BASED FDG PET/CT RADIOMICS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Shreve, Jacob, et al.
Publicado: (2023)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

Polymicrobial Pyomyositis in a Patient with Suspected Myeloma on (18)F-FDG PET-CT
por: Kalra, Simran, et al.
Publicado: (2022)

Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma
por: Lütje, Susanne, et al.
Publicado: (2009)

A Rare Extramedullary Presentation of Multiple Myeloma: Paraspinal Muscle Involvement Revealed by FDG PET/CT
por: Özkan, Elgin, et al.
Publicado: (2021)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Comparison of (11)C-4′-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma
por: Okasaki, Momoko, et al.
Publicado: (2014)

Radiomic analysis for predicting prognosis of colorectal cancer from preoperative (18)F-FDG PET/CT
por: Lv, Lilang, et al.
Publicado: (2022)

Frontiers and hotspots of (18)F-FDG PET/CT radiomics: A bibliometric analysis of the published literature
por: Liu, Xinghai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0sklrhaa81vosr1t5csq610v9l